Richard C Hom

Title: Innovations of Richard C Hom in Pharmaceutical Formulations

Introduction

Richard C Hom is a notable inventor based in Wilmette, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of extended release formulations. With a total of 2 patents, his work has focused on improving the efficacy and patient experience of medication.

Latest Patents

One of Richard C Hom's latest patents involves the creation of extended release formulations of erythromycin derivatives. This innovative pharmaceutical composition is designed to release the erythromycin derivative in the gastrointestinal environment. The formulation includes a pharmaceutically acceptable polymer, which allows for a statistically significant reduction in plasma concentration compared to immediate release compositions. Importantly, it maintains bioavailability and minimum concentration levels that are substantially equivalent to those of immediate release formulations upon multiple dosing. Additionally, these compositions offer an improved taste profile and reduced gastrointestinal side effects, enhancing the overall patient experience.

Career Highlights

Richard C Hom has been associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on developing advanced pharmaceutical solutions that address patient needs effectively.

Collaborations

Throughout his career, Richard has collaborated with esteemed colleagues such as Gerard F Notario and Robert N Palmer. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Richard C Hom's innovative work in the field of pharmaceutical formulations exemplifies the impact of research and development on patient care. His contributions continue to shape the landscape of medication delivery systems, ensuring better health outcomes for patients.